Law Offices of Howard G. Smith announces an investigation on behalf of Encompass Health Corporation (“Encompass” or the “Company”) (NYSE: EHC) investors concerning the Company’s possible violations of federal securities laws.

IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN ENCOMPASS HEALTH CORPORATION (EHC), CONTACT THE LAW OFFICES OF HOWARD G. SMITH ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS.

Contact the Law Offices of Howard G. Smith to discuss your legal rights by email at howardsmith@howardsmithlaw.com, by telephone at (215) 638-4847 or visit our website at www.howardsmithlaw.com.

What Happened?

On July 15, 2025, The New York Times published an article alleging, among other things, that federal data and inspection reports show that for-profit hospitals run by Encompass perform below average on key safety measures. The article revealed “Encompass owns many of the rehabs with worse rates of potentially preventable, unplanned readmissions to general hospitals” including 34 facilities which “Medicare rated as having statistically significantly worse rates of potentially preventable readmissions.” The report further revealed a number of “alarming mistakes” leading to fatalities of patients in their care.

On this news, Encompass’s stock price fell $12.39, or 10.4%, to close at $107.28 per share on July 15, 2025, thereby injuring investors.

Contact Us To Participate or Learn More:

If you purchased Encompass securities, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact us:

Law Offices of Howard G. Smith,

3070 Bristol Pike, Suite 112,

Bensalem, Pennsylvania 19020,

Telephone: (215) 638-4847

Email: howardsmith@howardsmithlaw.com,

Visit our website at: www.howardsmithlaw.com.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250717740934/en/